Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis—time to reconsider treatment guidelines? A case series and review of literature

[1]  W. Maloney,et al.  Diagnosis of Osteonecrosis of the Femoral Head: Too Little, Too Late, and Independent of Etiology. , 2020, The Journal of arthroplasty.

[2]  Siddharth Singh,et al.  Comparative Risk of Cardiovascular Events With Biologic and Synthetic Disease‐Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: A Systematic Review and Meta‐Analysis , 2020, Arthritis care & research.

[3]  L. Gensler,et al.  Biologic therapy and spinal radiographic progression in patients with axial spondyloarthritis: A structured literature review , 2020, Therapeutic advances in musculoskeletal disease.

[4]  M. Ward,et al.  2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis , 2019, Arthritis care & research.

[5]  R. Landewé,et al.  Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis , 2018, Rheumatology.

[6]  Désirée van der Heijde,et al.  TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort , 2017, Annals of the rheumatic diseases.

[7]  P. V. van Ooijen,et al.  Reduction in Spinal Radiographic Progression in Ankylosing Spondylitis Patients Receiving Prolonged Treatment With Tumor Necrosis Factor Inhibitors , 2016, Arthritis care & research.

[8]  Raveendhara R. Bannuru,et al.  2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis , 2016, Arthritis care & research.

[9]  Charles King,et al.  2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis , 2016, Arthritis & rheumatology.

[10]  G. Jürgens,et al.  Effect of Combination Therapy on Joint Destruction in Rheumatoid Arthritis: A Network Meta-Analysis of Randomized Controlled Trials , 2014, PloS one.

[11]  J. Reveille,et al.  The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis. , 2013, Arthritis and rheumatism.

[12]  S. Moon,et al.  Etanercept Treatment in Ankylosing Spondylitis Hip Lesions , 2013 .

[13]  D. Karras,et al.  Absence of radiographic progression of hip arthritis during infliximab treatment for ankylosing spondylitis , 2013, Clinical Rheumatology.

[14]  J. Reveille,et al.  Functional Limitations Due to Axial and Peripheral Joint Impairments in Patients With Ankylosing Spondylitis: Are Focused Measures More Informative? , 2013, Arthritis care & research.

[15]  J. Reveille,et al.  Regional radiographic damage and functional limitations in patients with ankylosing spondylitis: Differences in early and late disease , 2013, Arthritis care & research.

[16]  Z. Zhan,et al.  Treatment efficacy of etanercept and MTX combination therapy for ankylosing spondylitis hip joint lesion in Chinese population , 2012, Rheumatology International.

[17]  K. Ikari,et al.  Reparative radiological changes of a large joint after adalimumab for rheumatoid arthritis , 2011, Clinical Rheumatology.

[18]  Tsutomu Takeuchi,et al.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update , 2010, Annals of the rheumatic diseases.

[19]  Toong-Hua Liang,et al.  Differences Between Juvenile‐onset Ankylosing Spondylitis and Adult‐onset Ankylosing Spondylitis , 2009, Journal of the Chinese Medical Association : JCMA.

[20]  R N Maini,et al.  Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study. , 2005, Arthritis and rheumatism.

[21]  L. Klareskog,et al.  Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial , 2004, The Lancet.

[22]  E. Bouajina,et al.  Reparative radiological changes of hip joint after TNF inhibitors in ankylosing spondylitis , 2018, Caspian journal of internal medicine.

[23]  Raveendhara R. Bannuru,et al.  American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis , 2015 .

[24]  F. Breedveld,et al.  The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. , 2006, Arthritis and rheumatism.